← Back to guidelines
Cardiology325 papers

Coronary artery thrombosis

Last edited: 4/15/2026

Overview

Coronary artery thrombosis refers to the formation of a thrombus within a coronary artery, often associated with congenital anomalies such as anomalous aortic origin of a coronary artery, leading to myocardial ischemia and potential sudden death 12.

Diagnosis

  • Key Diagnostic Criteria: Identification of anomalous coronary artery origin and course, particularly when originating from the wrong aortic sinus or coursing between the aorta and pulmonary arteries 3.
  • Recommended Tests: Cardiac CT angiography for noninvasive evaluation of coronary origins and courses 3.
  • Grading: Imaging findings are graded based on anatomical abnormalities and potential hemodynamic impact 12.
  • Management

  • First-Line Treatments: Immediate stabilization with antiplatelet agents (e.g., aspirin) and anticoagulation (e.g., heparin) to prevent further thrombus propagation 1.
  • Adjunctive Treatments: Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for significant thrombotic occlusion or underlying anomalies 1.
  • Specific Drug Classes: Antiplatelet therapy (aspirin, P2Y12 inhibitors) and anticoagulation (warfarin, direct oral anticoagulants) tailored to clinical scenario 1.
  • Special Populations

  • Pediatrics: Congenital anomalies are more prevalent; careful preoperative imaging and risk stratification are crucial 12.
  • Athletes: Increased vigilance for asymptomatic anomalies detected via cardiac CT, given risk of sudden cardiac events 3.
  • Key Recommendations

  • Utilize cardiac CT angiography for definitive diagnosis of coronary artery anomalies in symptomatic patients, facilitating early intervention 3 (Evidence: Moderate).
  • Implement antiplatelet therapy and anticoagulation as initial management strategies for acute thrombosis, with revascularization considered based on severity 1 (Evidence: Moderate).
  • Tailor anesthetic and surgical approaches in patients with anomalous aortic origin of coronary arteries to mitigate perioperative risks 1 (Evidence: Expert opinion).
  • References

    1 Kloesel B, Richtsfeld M, Konia M, Bass JL. Management and Anesthetic Considerations for Patients With Anomalous Aortic Origin of a Coronary Artery. Seminars in cardiothoracic and vascular anesthesia 2018. link 2 Pérez-Pomares JM, de la Pompa JL, Franco D, Henderson D, Ho SY, Houyel L et al.. Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology--a position statement of the development, anatomy, and pathology ESC Working Group. Cardiovascular research 2016. link 3 Rommel M, Griffin R, Harrison EE. Coronary anomalies: cardiac CT evaluation of the symptomatic adult athlete. Current sports medicine reports 2007. link

    Original source

    1. [1]
      Management and Anesthetic Considerations for Patients With Anomalous Aortic Origin of a Coronary Artery.Kloesel B, Richtsfeld M, Konia M, Bass JL Seminars in cardiothoracic and vascular anesthesia (2018)
    2. [2]
    3. [3]
      Coronary anomalies: cardiac CT evaluation of the symptomatic adult athlete.Rommel M, Griffin R, Harrison EE Current sports medicine reports (2007)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG